SpecificationsOrganism/cell line/tissueHuman normal oral keratinocytesSex*N/A*Sequencer or array typeAffymetrix Human Genome Plus 2.0Data formatRaw and analyzedExperimental factorsNormal oral keratinocytes treated with EtOH and/or nicotineExperimental featuresTime and dose dependency exposure experiment to compare molecular effects of EtOH and nicotine in normal human oral keratinocytesConsent*N/A*Sample source location*N/A*

Direct link to deposited data {#s0030}
=============================

<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57634>

Experimental design, materials and methods {#s0005}
==========================================

Cell culture {#s0010}
------------

Primary normal human oral keratinocytes (NHOKs) were prepared from normal oral mucosal tissues according to methods described in elsewhere [@bb0005]. The isolation of primary cells was approved by the Institutional Review Board (IRB) under the protocol \# IRB10-000222. Briefly, discarded normal human oral mucosal tissues from routine periodontal surgery were obtained and stored in MEM/Ca^2 +^ free medium containing 3 × gentamycin (Invitrogen, Carlsbad, CA). Oral mucosal tissues were cut into small pieces and incubated in Dispase solution (Invitrogen) for 1 h in at 37 °C. Epithelial tissues were gently separated from the underlying connective tissues and minced into smaller pieces. Minced samples were then trypsinized in 37 °C for 3--5 min, and trypsinization is inactivated with the equal amount of fetal bovine serum (FBS; Invitrogen). Trypsinized keratinocytes were then collected, washed, seeded onto the dish, and maintained in EpiLife (Cascade Biologics, Portland, OR) supplemented with Human Keratinocytes Growth Supplement (HKGS) kit (Life Technologies, Grand Island, NY). Minimal passage number was maintained to prevent cell senescence. A maximum 60% confluence was maintained to prevent contact growth inhibition. The morphology of NHOK was confirmed under a 20 × inverted light microscope. NHOKs were transferred to 6 well tissue culture treated plates (34.8 mm diameter). NHOKs were treated with ethanol (0, 20 and 50 mM) and/or nicotine (0, 0.5 and 1 μM) in biological duplicates. After 24 h, media was removed and the cells were washed twice with PBS.

RNA isolation {#s0015}
-------------

Total RNA was isolated from NHOK treated with ethanol (0, 20, 50 mM) and/or nicotine (0, 0.5 and 1 μM) for 24 h. RNA was extracted using a RNeasy purification kit, following the manufacturer\'s instruction (Qiagen). Isolated RNA was further purified by DNAse treatment (Promega). RNA purity and concentration was determined by NanoDrop, ND-1000 spectrophotometer (Thermo) and microfluidics-based platform 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). RNA concentration ranged from 85 ng/ul to 438.5 ng/ul. RNA concentration \>=50 ng/μl is recommended for the subsequent microarray analysis. A 260/280 ratio ranged from 2.03 to 2.1. The ideal 260/280 ratio for pure RNA is 2.0.

Gene expression microarray analysis {#s0020}
-----------------------------------

Biological duplicate samples were hybridized to Affymetrix Human Genome Plus 2.0 (Cat.\# 900469). We set target intensity (TGT) at 500. The sensitivity of the system was measured by %P using the 3′ biased Affymetrix HG-U133A 2.0 arrays. %P ranged from 46.5 to 48.8% demonstrating the ability to detect a large number of transcripts across a wide range of abundance. All 18 arrays were assessed for recommended standard quality control metrics by Affymetrix including image quality, signal distribution and pairwise scatter plots and passed. mas5.CHP files were generated for each array by MAS 5.0 (Affymetrix) and combined to a final RESULTS.MAS5.TXT file.

Data analysis {#s0025}
-------------

Degradation plot was prepared with each curve corresponding to a single chip and visualizing the chip-averaged dependency between probe intensity and probe position ([Fig. 1](#f0005){ref-type="fig"}A). Raw data was initialized and analyzed for the quality of microarray analysis by log density estimates of the data across all arrays ([Fig. 1](#f0005){ref-type="fig"}B).

We performed background correction ([Fig. 2](#f0010){ref-type="fig"}), quantile normalization and log transformation with Robust Multi-array Average (RMA) approach on Affymetrix gene expression data using "Affy" R package ([Fig. 3](#f0015){ref-type="fig"}) [@bb0010].

We removed probes with expression lower than the overall sample median; 27,061 out of 54,676 probes were kept for further analysis.

Further data analysis was performed according to the Weighted Gene Co-expression Network Analysis (WGCNA) package tutorial written by Peter Langfelder and Steve Horvath [@bb0015]. The complete tutorial including necessary codes to run the analysis is publically available from <http://labs.genetics.ucla.edu/horvath/CoexpressionNetwork/Rpackages/WGCNA/Tutorials/>. The latest R (R-3.0.0) was downloaded to iMAC 2.9 GHz quad-core Intel Core i5 with 8 GB 1600 MHz DDR3 memory. Package WGCNA 1.36 was installed in conjunction with dynamicTreeCut, cluster, flashClust, Hmisc, reshape, foreach, and doParallel. Before data can be loaded to WGCNA, pre-processing step is necessary. Generally, WGCNA associated files should be in CSV file format without spaces, special characters and/or empty cells in their file names, as well as in their columns and rows within the files themselves. WGCNA_matrix.CSV was made from the final RESULTS.MAS5.TXT file. An example of the first ten rows from the WGCNA_matrix.CGV is shown in [Table 1](#t0005){ref-type="table"}.

A sample_annotation.CSV was made using the corresponding transposed columns from 18 arrays including control and different combinations of ethanol and/or nicotine treatment ([Table 2](#t0010){ref-type="table"}).

The WGCNA_matrix.CSV and the sample_annotation.CSV were read by WGCNA and sample dendogram and trait heatmap was plotted based on their Euclidean distance ([Fig. 4](#f0020){ref-type="fig"}).

The sample dendogram and trait heatmap allows the users to check the data for excessive missing values and visualize obvious outlier samples. Next, a soft threshold power beta value based on the scale free topology was calculated. This is a critical step since the success of subsequent network construction and identification of modules depends on choosing the most ideal soft threshold power beta value. WGCNA allows the users to choose an automated "convenient-1-step method" or more customizable step-by-step method. It is important to maximize scale-free topology model fit (R\^2) while maintaining a high mean number of connections. Generally, R\^2 should be close to 1, the mean connectivity should be high so that the network contains enough information. The slope of the regression line should be close to − 1. We chose the soft threshold power beta = 9 since this was where the curve reached a saturation point in the Soft Threshold (SFT) graph ([Fig. 5](#f0025){ref-type="fig"}).

Once the Soft threshold power beta value was chosen based on the criterion of approximate scale-free topology, we turned the adjacencies into Topological Overlap Matrix (TOM). The main objective of our study was to identify changes in biological function and pathway of normal oral keratinocytes due to EtOH and/or nicotine. Although it is possible to simply rank microarray expression data based on the fold change alone, the strength of WGCNA comes from its robustness and sensitivity to identify genes/proteins of interest and its ability to cluster genes of interest into a module based on their interconnectedness [@bb0020]. We set merging threshold value at 0.25, beta power value at 9, maximum block size at 10,000 and minimum module size at 1000. The rest of the "blockwiseModules" function was left at its default values. The result from automatic module detection via dynamic tree cutting is shown in [Fig. 6](#f0030){ref-type="fig"}.

In total, we found that genes from NHOKs treated with EtOH and/or nicotine were divided into six blocks and clustered into 14 distinctive modules using WGCNA (data not shown). [Fig. 3](#f0015){ref-type="fig"} represents block 1 which contains two modules: turquoise and brown. Turquoise module had 15,174 genes. The 15,174 genes showed down-regulation by co-treatment of EtOH and nicotine compared to control. The turquoise module also contained genes that were downregulated upon EtOH treatment regardless of EtOH concentration. For nicotine, it seemed like the 0.5 μM nicotine treatment showed more significant change than the 1.0 μM concentration at least within the turquoise module.

In conclusion, we demonstrated that a complex dataset from microarray experiment can be analyzed effectively using WGCNA. Once the interesting modules are identified by WGCNA analysis, the modules can be related to external traits (i.e. EtOH/nicotine related cancers), used to find key drivers a.k.a. hub genes, and used for downstream functional annotation (i.e. DAVID analysis).

This work was supported by the UCLA Faculty Seed Grant and NIH/NIAAA R01 grant (R01AA21301) to Y.K.

![A. Degradation plot: Each curve corresponds to a single chip and visualizes the chip-averaged dependency between probe intensity and probe position. B. Log density estimates (histograms) of the data across arrays.](gr1){#f0005}

![Quality control statistics. Each array is presented by a separated line. The blue bar represents the region where all scale factor fall within 3-fold of the mean scale factor for all chips. The chips passed all the QC metrics, indicating good quality data.](gr2){#f0010}

![Boxplot of intensity for each sample after normalization and log transformation by using (A) Mas5 method and (B) Robust Multi-array Average (RMA) method.](gr3){#f0015}

![Sample dendrogram and trait heatmap (WGCNA output). This is the first output data using WGCNA. The sample dendrogram allows users to visualize how the samples are cluster and identify any obvious outliers. EtOH0nicotine05_1 falls into possible outlier category. Outlier can be removed by editing the original WGCNA_matrix.CSV manually or the user can choose to set a limit on height to remove the outlier.](gr4){#f0020}

![Threshold beta value calculation (WGCNA output). The left panel shows the Scale-Free Topology (SFT) Index in *y*-axis as a function of the Soft Threshold in *x*-axis. The graph is reaching a saturation point at threshold beta value = 9. The right panel shows the Mean Connectivity in *y*-axis as a function of the Soft Threshold in *x*-axis. The slope of the regression line should be close to − 1.](gr5){#f0025}

![Module detection via dynamic tree cutting (WGCNA output). Each vertical line a.k.a. "leaf" represents a gene. A group of leaves form a "branch" which is densely interconnected co-expressing genes. Multiple branches converge into a tree which corresponds to a module. A random color is assigned to a module (i.e. turquoise and brown are shown here). Heatmaps show expression level of genes from corresponding experimental group (shown on left with starting with "cor.") and denoted module (shown by "Module colors"). Heatmaps: Red --- positive, green --- negative.](gr6){#f0030}

###### 

Details of WGCNA_matrix.CSV (WGCNA input). The first row describes the experimental condition that NHOKs were exposed to. It contains information on different concentration of EtOH and/or nicotine used on NHOKs (0 = no treatment, 20 = 20 mM EtOH, 50 = 50 mM EtOH, 05 = 0.5 μM nicotine, 1 = 1.0 μM nicotine, \_1 = 1 of 2 in biological duplicates, \_2 = 2 of 2 in biological duplicates). The first column contains ProbeSetID representing a defined probe from affymetrix microarray. Only first ten rows are shown.

  ProbeSet ID   EtOHOnicotineO 1   EtOHOnicotineO 2   EtOHOnicotineOS 1   EtOH50nicotinc05 2   EtOHSOnicotinel 1   EtOHSOnicotinel 2
  ------------- ------------------ ------------------ ------------------- -------------------- ------------------- -------------------
  1007_s\_at    5981.038           5889.953           6831.399            5330.862             5741.348            5483.501
  1053_at       660.922            900.0433           747.627             814.9226             1019.678            697.8356
  117_at        77.72807           46.67521           103.4658            99.7991              79.94872            51.02247
  121_at        528.5612           613.58             498.6766            486.1765             458.8339            429.0858
  1255_g\_at    5.511828           4.936847           10.26788            2.371168             19.53059            4.99963
  1294_at       200.1463           199.8828           255.2035            166.7272             173.7267            165.8017
  1316_at       152.9277           134.7367           230.6803            103.8526             126.7582            98.9052
  1320_at       74.21634           45.85337           96.10732            82.3228              81.87113            67.86658
  1405_i\_at    84.68176           56.01822           62.11277            68.74342             62.43927            64.13792
  1431_at       26.04898           22.96477           37.09872            37.06742             18.30075            9.857845

###### 

Details of sample_annotation.CSV (WGCNA input). The sample annotation file contains information on how the samples should be ordered and which samples should be compared. Second column should reflect the first ro w from WGCNA_matric.CSV exactly. Columns three to ten are user defined depending on the user\'s specific hypothesis. For example, if the user wishes to compare control and EtOH + nicotine, then a comparison analysis between column three and four would be appropriate. 0\'s and 1\'s in each cell reflect corresponding binary information (0 = negative and 1 = positive).

  OriginalOrder   ProbeSetID           Control   EtOH_and_Nicotine   EtOH_0   EtOH_20   EtOH_50   Nicotine_0   Nicotine_05   Nicotine_l
  --------------- -------------------- --------- ------------------- -------- --------- --------- ------------ ------------- ------------
  1               EtOHOnicotineO_l     1         0                   1        0         0         1            0             0
  2               EtOHOnicotineO_2     1         0                   1        0         0         1            0             0
  3               EtOH0nicotine05_l    0         0                   1        0         0         0            1             0
  4               EtOH0nicotine05_2    0         0                   1        0         0         0            1             0
  5               EtOHOnicotinel_l     0         0                   1        0         0         0            0             1
  6               EtOHOnicotinel_2     0         0                   1        0         0         0            0             1
  7               EtOH20nicotine0_l    0         0                   0        1         0         0            0             0
  8               EtOH20nicotineO_2    0         0                   0        1         0         0            0             0
  9               EtOH20nicotine05_l   0         1                   0        1         0         0            0             0
  10              EtOH20nicotine05_2   0         1                   0        1         0         0            0             0
  11              EtOH20nicotinel_l    0         1                   0        1         0         0            0             0
  12              EtOH20nicotinel_2    0         1                   0        1         0         0            0             0
  13              EtOH50nicotine0_l    0         0                   0        0         1         1            0             0
  14              EtOH50nicotineO_2    0         0                   0        0         1         1            0             0
  15              EtOH50nicotine05_l   0         1                   0        0         1         0            1             0
  16              EtOH50nicotine05_2   0         1                   0        0         1         0            1             0
  17              EtOH50nicotinel_l    0         1                   0        0         1         0            0             1
  18              EtOH50nicotinel_2    0         1                   0        0         1         0            0             1
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